Results
Dr. Reddy's Q1FY27 Net Profit Drops 69% YoY
Board approved Q1FY27 unaudited results with revenue of ₹80.7B, down 5.6% YoY, and net profit of ₹4.4B, down 69% YoY, impacted by a ₹2.4B semaglutide API provision.
Appointed Dr. Sridevi Khambhampaty
